Entry Point Capital, LLC Adaptive Biotechnologies Corp Call Options Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ADPT
# of Institutions
185Shares Held
154MCall Options Held
8.4KPut Options Held
56K-
Viking Global Investors LP30MShares$169 Million0.43% of portfolio
-
Rubric Capital Management LP New York, NY14MShares$78.8 Million1.5% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$65.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$65.3 Million0.56% of portfolio
-
Matrix Capital Management Company, LP Waltham, MA11.6MShares$65.2 Million0.32% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $804M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...